The emergence of telemedicine has accelerated during the coronavirus pandemic.
Regulations on telehealth services were rapidly deregulated early into the COVID-19 pandemic, but questions remain about quality of care and patient disparities.
Monitoring hematological and coagulation parameters with rapid blood tests may aid clinicians in the prognosis and severity assessment of COVID-19.
Vaccination with mRNA-1273, Moderna’s coronavirus disease 2019 (COVID-19) vaccine candidate, led to robust immune responses and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates.
The American College of Cardiology has released guidance on pediatric return-to-play for sports participation following COVID-19 infection.
The US Department of Health and Human Services and the Department of Defense have agreed to receive 100 million doses of BNT162, a vaccine for SARS-CoV-2, once the manufacturers obtains approval or emergency use authorization (EUA) from the Food and Drug Administration.
Despite treatment with antiretroviral therapies, people with HIV may be more likely to experience severe manifestations of COVID-19.
The FDA has granted Fast Track designation to 2 of Pfizer and BioNTech’s vaccine candidates against COVID-19.
The global population is anticipated to peak in 2064 and then decline to year 2100.
The increased risk for frequent nonmedical cannabis use among individuals with pain was elevated when comparing between surveys in the 2 time periods.